These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 21596085)

  • 1. HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line.
    Tagliamonte M; Visciano ML; Tornesello ML; De Stradis A; Buonaguro FM; Buonaguro L
    Vaccine; 2011 Jul; 29(31):4913-22. PubMed ID: 21596085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive expression of HIV-VLPs in stably transfected insect cell line for efficient delivery system.
    Tagliamonte M; Visciano ML; Tornesello ML; De Stradis A; Buonaguro FM; Buonaguro L
    Vaccine; 2010 Sep; 28(39):6417-24. PubMed ID: 20678589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of HIV-1 Virus-Like Particles expressing different HIV-1 glycoproteins.
    Visciano ML; Diomede L; Tagliamonte M; Tornesello ML; Asti V; Bomsel M; Buonaguro FM; Lopalco L; Buonaguro L
    Vaccine; 2011 Jul; 29(31):4903-12. PubMed ID: 21596074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K; Forman J; Kräusslich HG; Rose JK
    Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential budding efficiencies of human T-cell leukemia virus type I (HTLV-I) Gag and Gag-Pro polyproteins from insect and mammalian cells.
    Bouamr F; Garnier L; Rayne F; Verna A; Rebeyrotte N; Cerutti M; Mamoun RZ
    Virology; 2000 Dec; 278(2):597-609. PubMed ID: 11118382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chimeric HIV-1 virus-like particles containing gp120 epitopes as a result of a ribosomal frameshift elicit Gag- and SU-specific murine cytotoxic T-lymphocyte activities.
    Tobin GJ; Li GH; Fong SE; Nagashima K; Gonda MA
    Virology; 1997 Sep; 236(2):307-15. PubMed ID: 9325238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Japanese encephalitis virus-based replicon RNAs/particles as an expression system for HIV-1 Pr55 Gag that is capable of producing virus-like particles.
    Yun SI; Song BH; Koo Y; Jeon I; Byun SJ; Park JH; Joo YS; Kim SY; Lee YM
    Virus Res; 2009 Sep; 144(1-2):298-305. PubMed ID: 19406175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain.
    Deml L; Kratochwil G; Osterrieder N; Knüchel R; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):10-25. PubMed ID: 9300033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of high levels of chimeric human immunodeficiency virus envelope glycoproteins into virus-like particles.
    Wang BZ; Liu W; Kang SM; Alam M; Huang C; Ye L; Sun Y; Li Y; Kothe DL; Pushko P; Dokland T; Haynes BF; Smith G; Hahn BH; Compans RW
    J Virol; 2007 Oct; 81(20):10869-78. PubMed ID: 17670815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
    Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
    Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimaeric HIV-1 subtype C Gag molecules with large in-frame C-terminal polypeptide fusions form virus-like particles.
    Halsey RJ; Tanzer FL; Meyers A; Pillay S; Lynch A; Shephard E; Williamson AL; Rybicki EP
    Virus Res; 2008 May; 133(2):259-68. PubMed ID: 18329748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products.
    Wang CT; Li JJ; Lai HY; Hu BS
    J Med Virol; 1999 Jan; 57(1):17-24. PubMed ID: 9890417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.
    Yamaji H
    Appl Microbiol Biotechnol; 2014 Mar; 98(5):1963-70. PubMed ID: 24407451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations in the protease gene of human immunodeficiency virus type 1 affect release and stability of virus particles.
    Park J; Morrow CD
    Virology; 1993 Jun; 194(2):843-50. PubMed ID: 8503189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myristoylation of human immunodeficiency virus type 1 gag protein is required for efficient env protein transportation to the surface of cells.
    Shiraishi T; Misumi S; Takama M; Takahashi I; Shoji S
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1201-5. PubMed ID: 11302743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RMCE-based insect cell platform to produce membrane proteins captured on HIV-1 Gag virus-like particles.
    Vidigal J; Fernandes B; Dias MM; Patrone M; Roldão A; Carrondo MJT; Alves PM; Teixeira AP
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):655-666. PubMed ID: 29143881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies.
    Ye L; Lin J; Sun Y; Bennouna S; Lo M; Wu Q; Bu Z; Pulendran B; Compans RW; Yang C
    Virology; 2006 Aug; 351(2):260-70. PubMed ID: 16678231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of V3-specific cytotoxic T lymphocyte responses by HIV gag particles carrying multiple immunodominant V3 epitopes of gp120.
    Luo L; Li Y; Chang JS; Cho SY; Kim TY; Choi MJ; Cheong HS; Kim HJ; Ahn HJ; Min MK; Chun BH; Jung SM; Woo SG; Park SY; Kang CY
    Virology; 1998 Jan; 240(2):316-25. PubMed ID: 9454705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.